Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors.

about

Lactobacilli Modulate Hypoxia-Inducible Factor (HIF)-1 Regulatory Pathway in Triple Negative Breast Cancer Cell Line.Evolutionarily conserved dual lysine motif determines the non-chaperone function of secreted Hsp90alpha in tumour progression.

P2860

Q37183234-BA1F9FB3-C35F-4E20-929B-E16167806199 Q37746398-5C95ED64-7E75-46C2-9C0D-EA964CF2814D

P2860

Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors.

Item

http://www.wikidata.org/entity/Q35763206

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors.

@ast

Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors.

@en

type

Item

label

Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors.

@ast

Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors.

@en

prefLabel

Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors.

@ast

Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors.

@en

P1476

Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors.

@en

P2093

Charan V Devarakonda

http://www.w3.org/2001/XMLSchema#string

Daniel Kita

http://www.w3.org/2001/XMLSchema#string

Kathryn N Phoenix

http://www.w3.org/2001/XMLSchema#string

Kevin P Claffey

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90

Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization

Overview of monoclonal antibodies in cancer therapy: present and promise

Hsp90 isoforms: functions, expression and clinical importance

Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness

Antibody therapy of cancer

The regulatory mechanism of Hsp90alpha secretion and its function in tumor malignancy

Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion

P2888

s12885-015-1608-z

P304

614

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-015-1608-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281541494

http://www.w3.org/2001/XMLSchema#string

P6179

1036307975

http://www.w3.org/2001/XMLSchema#string

P698

26334999

http://www.w3.org/2001/XMLSchema#string

P932

4559304

http://www.w3.org/2001/XMLSchema#string

Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors.

about

P2860

P2860

Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P5875

P6179

P698

P932